Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

NCT05868148 is registered in ClinicalTrials.gov with Stryker Trauma and Extremities as lead sponsor.

NCT NCT05868148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05868148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
Lead sponsor
Stryker Trauma and Extremities
Phase
Observational
Overall status
Active, not recruiting
Start date
October 20, 2023
Completion date
December 31, 2035
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis of the head of humerus, fracture, humeral, osteoarthritis shoulder, rheumatoid arthritis shoulder, rotator cuff tears, shoulder deformity, traumatic arthritis of right shoulder region (diagnosis)